Literature DB >> 10891445

Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysis during acute arterial thrombosis in mice.

T Kawasaki1, M Dewerchin, H R Lijnen, J Vermylen, M F Hoylaerts.   

Abstract

The role of plasminogen activator inhibitor-1 (PAI-1) in the plasma, blood platelets, and vessel wall during acute arterial thrombus formation was investigated in gene-deficient mice. Photochemically induced thrombosis in the carotid artery was analyzed via transillumination. In comparison to thrombosis in C57BL/6J wild-type (wt) mice (113 +/- 19 x 10(6) arbitrary light units [AU] n = 15, mean +/- SEM), thrombosis in PAI-1(-/-) mice (40 +/- 10 x 10(6) AU, n = 13) was inhibited (P <.01), indicating that PAI-1 controls fibrinolysis during thrombus formation. Systemic administration of murine PAI-1 into PAI-1(-/-) mice led to a full recovery of thrombotic response. Occurrence of fibrinolytic activity was confirmed in alpha(2)-antiplasmin (alpha(2)-AP)-deficient mice. The sizes of thrombi developing in wt mice, in alpha(2)-AP(+/-) and alpha(2)-AP(-/-) mice were 102 +/- 35, 65 +/- 8.1, and 13 +/- 6.1 x 10(6) AU, respectively (n = 6 each) (P <.05), compatible with functional plasmin inhibition by alpha(2)-AP. In contrast, thrombi in wt mice, t-PA(-/-) and u-PA(-/-) mice were comparable, substantiating efficient inhibition of fibrinolysis by the combined PAI-1/alpha(2)-AP action. Platelet depletion and reconstitution confirmed a normal thrombotic response in wt mice, reconstituted with PAI-1(-/-) platelets, but weak thrombosis in PAI-1(-/-) mice reconstituted with wt platelets. Accordingly, murine (wt) PAI-1 levels in platelet lysates and releasates were 0.43 +/- 0.09 ng/10(9) platelets and plasma concentrations equaled 0.73 +/- 0.13 ng/mL. After photochemical injury, plasma PAI-1 rose to 2.9 +/- 0.7 ng/mL (n = 9, P <.01). The plasma rise was prevented by ligating the carotid artery. Hence, during acute thrombosis, fibrinolysis is efficiently prevented by plasma alpha(2)-AP, but also by vascular PAI-1, locally released into the circulation after endothelial injury.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10891445

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

Review 1.  Genetic Effects on the Correlation Structure of CVD Risk Factors: Exome-Wide Data From a Ghanaian Population.

Authors:  Nuri Kodaman; Rafal S Sobota; Folkert W Asselbergs; Matthew T Oetjens; Jason H Moore; Nancy J Brown; Melinda C Aldrich; Scott M Williams
Journal:  Glob Heart       Date:  2017-04-10

2.  Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy.

Authors:  Anne Angelillo-Scherrer; Laurent Burnier; Nathalie Flores; Pierre Savi; Maria DeMol; Paul Schaeffer; Jean-Marc Herbert; Greg Lemke; Stephen P Goff; Glenn K Matsushima; H Shelton Earp; Christian Vesin; Marc F Hoylaerts; Stéphane Plaisance; Désiré Collen; Edward M Conway; Bernhard Wehrle-Haller; Peter Carmeliet
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

3.  Does plasmin have anticoagulant activity?

Authors:  Jane Hoover-Plow
Journal:  Vasc Health Risk Manag       Date:  2010-04-15

4.  Evaluating PAI-1 as a biomarker for stress in diving: human serum total PAI-1 is unaltered after 2 h dry exposures to 280 kPa hyperbaric air.

Authors:  Ingrid Eftedal; Hallvard Aglen Fredriksen; Astrid Hjelde; Andreas Møllerløkken
Journal:  Physiol Rep       Date:  2015-06

5.  Hyperglycaemia-induced reciprocal changes in miR-30c and PAI-1 expression in platelets.

Authors:  Mao Luo; Rong Li; Meiping Ren; Ni Chen; Xin Deng; Xiaoyong Tan; Yongjie Li; Min Zeng; Yan Yang; Qin Wan; Jianbo Wu
Journal:  Sci Rep       Date:  2016-11-07       Impact factor: 4.379

6.  Genetics of Plasminogen Activator Inhibitor-1 (PAI-1) in a Ghanaian Population.

Authors:  Marquitta J White; Nuri M Kodaman; Reed H Harder; Folkert W Asselbergs; Douglas E Vaughan; Nancy J Brown; Jason H Moore; Scott M Williams
Journal:  PLoS One       Date:  2015-08-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.